Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    supriya kashyap kashyap
    supriya kashyap kashyap
      • Home
      • supriya kashyap...

      Articles By : supriya kashyap kashyap

      ICRA upgrades long term rating on Patanjali Ayurved

      ICRA upgrades long term rating on Patanjali Ayurved

      supriya kashyap kashyap21 Jan 2017 12:30 PM IST
      New Delhi : Credit rating agency ICRA has upgraded long term rating on Baba Ramdev-led Patanjali Ayurved Ltd (PAL) to enhanced degree of adequate...
      Pharma industry grows 29 percent to Rs 2.04 lakh crore in 2015-16

      Pharma industry grows 29 percent to Rs 2.04 lakh crore in 2015-16

      supriya kashyap kashyap21 Jan 2017 12:11 PM IST
      New Delhi : Indian pharmaceutical industry grew by 29 per cent to Rs 2,04,627 crore in 2015-16 from Rs 1,77,734 crore in 2014-15, while it attracted...
      Mallinckrodt to pay $100 million to settle US probe on drug pricing

      Mallinckrodt to pay $100 million to settle US probe on drug pricing

      supriya kashyap kashyap21 Jan 2017 12:10 PM IST
      Washington : Mallinckrodt Plc has agreed to pay $100 million to settle allegations that a subsidiary broke U.S. antitrust law by sharply increasing...
      Zydus Cadila acquires US-based Sentynl Therapeutics

      Zydus Cadila acquires US-based Sentynl Therapeutics

      supriya kashyap kashyap21 Jan 2017 11:19 AM IST
      New Delhi : Zydus Cadila said it has acquired Sentynl Therapeutics, a US-based pharma company specialised in marketing of products in the pain...
      FDA approves a generic of Xyrem to treat Cataplexy and excessive daytime sleepiness

      FDA approves a generic of Xyrem to treat Cataplexy and excessive daytime sleepiness

      supriya kashyap kashyap20 Jan 2017 12:09 PM IST
      The U.S. Food and Drug Administration (FDA) has approved the first generic version of Xyrem (sodium oxybate) Oral Solution, to treat cataplexy and...
      Zydus Cadila gets USFDA nod for chemotherapy drug

      Zydus Cadila gets USFDA nod for chemotherapy drug

      supriya kashyap kashyap20 Jan 2017 12:08 PM IST
      New Delhi : Drug firm Zydus Cadila said it has received approval from the US health regulator to market methotrexate tablets, a chemotherapy drug, in...
      McKesson in record $150 million US settlement over suspicious drug orders

      McKesson in record $150 million US settlement over suspicious drug orders

      supriya kashyap kashyap20 Jan 2017 11:22 AM IST
      McKesson Corp, one of the largest U.S. distributors of pharmaceutical drugs, will pay a record $150 million to resolve a U.S. investigation into...
      FIPB clears 6 FDI proposals worth Rs 1,187 crore

      FIPB clears 6 FDI proposals worth Rs 1,187 crore

      supriya kashyap kashyap20 Jan 2017 9:11 AM IST
      New Delhi : Inter-ministerial body FIPB approved six investment proposals, including that of Sanofi Synthelabo India, Star Den Media Services and Idea...
      Panacea inks pact with UNICEF, gets USFDA nod for migraine drug

      Panacea inks pact with UNICEF, gets USFDA nod for migraine drug

      supriya kashyap kashyap19 Jan 2017 11:40 AM IST
      New Delhi : Drug firm Panacea Biotec said it has inked a pact with UNICEF for supply of Pentavalent Vaccine (Easyfive-TT) in the current year.The...
      Cipla arm to sell stake in Four M Propack to Shriji Polymers

      Cipla arm to sell stake in Four M Propack to Shriji Polymers

      supriya kashyap kashyap19 Jan 2017 11:39 AM IST
      New Delhi : Drug major Cipla said its subsidiary Golden cross Pharma has entered into a pact to sell its entire stake in Four M Propack to Shriji...
      Healthcare tech VC funding in crosses $5bn: Mercom

      Healthcare tech VC funding in crosses $5bn: Mercom

      supriya kashyap kashyap19 Jan 2017 11:38 AM IST
      New Delhi : Venture capital (VC) funding, including private equity as well as corporate, rose to USD 5.1 billion in the healthcare IT sector last...
      FDA approves generic version of Jazz Pharma sleep disorder drug

      FDA approves generic version of Jazz Pharma sleep disorder drug

      supriya kashyap kashyap18 Jan 2017 12:24 PM IST
      The U.S. Food and Drug Administration said it had approved the first generic version of Xyrem, Jazz Pharmaceuticals Plc's drug to treat patients with...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok